Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marna G Bouwhuis

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
Molecular Oncology|March 4, 2011
Immunologic functions as prognostic indicators in melanomaMarna G Bouwhuis, Timo L M ten Hagen, Alexander M M Eggermont
Current Opinion in Oncology|December 15, 2010
Autoimmunity and treatment outcome in melanomaMarna G Bouwhuis, Timo L M Ten Hagen, Stefan Suciu, et al.
European Journal of Emergency Medicine : Official Journal of the European Society for Emergency Medicine|April 27, 2023
How to OPTIMIZE inclusions for emergency department researchEva E Schippers, Fien T Lobée, A Vanessa Brown, et al.
Cancer Immunology, Immunotherapy : CII|August 13, 2009
Polymorphisms in the CD28/CTLA4/ICOS genes: role in malignant melanoma susceptibility and prognosis?Marna G Bouwhuis, Andreas Gast, Adina Figl, et al.
Cancer Chemotherapy and Pharmacology|July 22, 2009
Serum concentrations of pegylated interferon alpha-2b in patients with resected stage III melanoma receiving adjuvant pegylated interferon alpha-2b in a randomized phase III trial (EORTC 18991)Alexander M M Eggermont, Marna G Bouwhuis, Wim H Kruit, et al.
International Journal of Emergency Medicine|January 25, 2022
Patient satisfaction, needs, and preferences concerning information dispensation at the emergency department: a cross-sectional observational studyMarank de Steenwinkel, Juanita A Haagsma, Esther C M van Berkel, et al.
European Journal of Emergency Medicine : Official Journal of the European Society for Emergency Medicine|August 26, 2020
Effect of written and video discharge instructions on parental recall of information about analgesics in children: a pre/post-implementation studyAmber E Hoek, Marna G Bouwhuis, Juanita A Haagsma, et al.
Melanoma Research|May 7, 2011
Changes of ferritin and CRP levels in melanoma patients treated with adjuvant interferon-α (EORTC 18952) and prognostic value on treatment outcomeMarna G Bouwhuis, Sandra Collette, Stefan Suciu, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 14, 2010
Phase III trial comparing adjuvant treatment with pegylated interferon Alfa-2b versus observation: prognostic significance of autoantibodies--EORTC 18991Marna G Bouwhuis, Stefan Suciu, Alessandro Testori, et al.
Plos One|May 21, 2024
Association between stringency of lockdown measures and emergency department visits during the COVID-19 pandemic: A Dutch multicentre studyF Marlijn Booij-Tromp, Nicole J van Groningen, Sebastian Vervuurt, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Molecular Oncology|March 4, 2011
Immunologic functions as prognostic indicators in melanomaMarna G Bouwhuis, Timo L M ten Hagen, Alexander M M Eggermont
Current Opinion in Oncology|December 15, 2010
Autoimmunity and treatment outcome in melanomaMarna G Bouwhuis, Timo L M Ten Hagen, Stefan Suciu, et al.
European Journal of Emergency Medicine : Official Journal of the European Society for Emergency Medicine|April 27, 2023
How to OPTIMIZE inclusions for emergency department researchEva E Schippers, Fien T Lobée, A Vanessa Brown, et al.
Cancer Immunology, Immunotherapy : CII|August 13, 2009
Polymorphisms in the CD28/CTLA4/ICOS genes: role in malignant melanoma susceptibility and prognosis?Marna G Bouwhuis, Andreas Gast, Adina Figl, et al.
Cancer Chemotherapy and Pharmacology|July 22, 2009
Serum concentrations of pegylated interferon alpha-2b in patients with resected stage III melanoma receiving adjuvant pegylated interferon alpha-2b in a randomized phase III trial (EORTC 18991)Alexander M M Eggermont, Marna G Bouwhuis, Wim H Kruit, et al.
International Journal of Emergency Medicine|January 25, 2022
Patient satisfaction, needs, and preferences concerning information dispensation at the emergency department: a cross-sectional observational studyMarank de Steenwinkel, Juanita A Haagsma, Esther C M van Berkel, et al.
European Journal of Emergency Medicine : Official Journal of the European Society for Emergency Medicine|August 26, 2020
Effect of written and video discharge instructions on parental recall of information about analgesics in children: a pre/post-implementation studyAmber E Hoek, Marna G Bouwhuis, Juanita A Haagsma, et al.
Melanoma Research|May 7, 2011
Changes of ferritin and CRP levels in melanoma patients treated with adjuvant interferon-α (EORTC 18952) and prognostic value on treatment outcomeMarna G Bouwhuis, Sandra Collette, Stefan Suciu, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 14, 2010
Phase III trial comparing adjuvant treatment with pegylated interferon Alfa-2b versus observation: prognostic significance of autoantibodies--EORTC 18991Marna G Bouwhuis, Stefan Suciu, Alessandro Testori, et al.
Plos One|May 21, 2024
Association between stringency of lockdown measures and emergency department visits during the COVID-19 pandemic: A Dutch multicentre studyF Marlijn Booij-Tromp, Nicole J van Groningen, Sebastian Vervuurt, et al.
Pageof 2